Cooper Companies, Inc. (The) (COO) CEO Sells $2,309,187.24 in Stock

Cooper Companies, Inc. (The) (NYSE:COO) CEO Paul L. Remmell sold 9,294 shares of the firm’s stock in a transaction that occurred on Friday, July 14th. The stock was sold at an average price of $248.46, for a total value of $2,309,187.24. Following the transaction, the chief executive officer now owns 6,186 shares of the company’s stock, valued at approximately $1,536,973.56. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Shares of Cooper Companies, Inc. (NYSE COO) traded up 0.39% during trading on Friday, reaching $240.92. The company’s stock had a trading volume of 286,217 shares. The company has a market cap of $11.77 billion, a PE ratio of 36.12 and a beta of 0.61. The firm’s 50-day moving average is $245.14 and its 200 day moving average is $214.89. Cooper Companies, Inc. has a 52-week low of $158.73 and a 52-week high of $256.39.

Cooper Companies, Inc. (The) (NYSE:COO) last announced its quarterly earnings results on Thursday, June 1st. The medical device company reported $2.50 EPS for the quarter, beating the Zacks’ consensus estimate of $2.25 by $0.25. Cooper Companies, Inc. (The) had a return on equity of 15.88% and a net margin of 16.02%. The company had revenue of $522.40 million during the quarter, compared to analysts’ expectations of $520.71 million. During the same period in the prior year, the company earned $2.05 EPS. Cooper Companies, Inc. (The)’s revenue was up 8.0% compared to the same quarter last year. On average, equities research analysts predict that Cooper Companies, Inc. will post $9.63 EPS for the current fiscal year.

The company also recently declared a semiannual dividend, which was paid on Monday, August 7th. Stockholders of record on Friday, July 21st were paid a $0.03 dividend. This represents a dividend yield of 0.02%. The ex-dividend date was Wednesday, July 19th. Cooper Companies, Inc. (The)’s payout ratio is 0.90%.

TRADEMARK VIOLATION NOTICE: This report was first reported by Community Financial News and is owned by of Community Financial News. If you are reading this report on another site, it was copied illegally and reposted in violation of United States & international trademark & copyright laws. The correct version of this report can be viewed at https://www.com-unik.info/2017/08/11/cooper-companies-inc-the-coo-ceo-paul-l-remmell-sells-9294-shares-of-stock-updated-updated-updated.html.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Dimensional Fund Advisors LP raised its position in shares of Cooper Companies, Inc. (The) by 3.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 176,074 shares of the medical device company’s stock valued at $30,801,000 after buying an additional 6,448 shares in the last quarter. UBS Asset Management Americas Inc. increased its stake in shares of Cooper Companies, Inc. (The) by 34.4% in the fourth quarter. UBS Asset Management Americas Inc. now owns 812,106 shares of the medical device company’s stock worth $142,062,000 after buying an additional 207,903 shares during the last quarter. Teachers Advisors LLC increased its stake in shares of Cooper Companies, Inc. (The) by 17.5% in the fourth quarter. Teachers Advisors LLC now owns 61,032 shares of the medical device company’s stock valued at $10,676,000 after buying an additional 9,089 shares in the last quarter. Kentucky Retirement Systems purchased a new stake in shares of Cooper Companies, Inc. (The) during the fourth quarter valued at approximately $619,000. Finally, Kentucky Retirement Systems Insurance Trust Fund purchased a new stake in shares of Cooper Companies, Inc. (The) during the fourth quarter valued at approximately $276,000. Institutional investors own 99.97% of the company’s stock.

Several equities analysts recently commented on COO shares. BMO Capital Markets restated an “outperform” rating and set a $255.00 target price (up previously from $220.00) on shares of Cooper Companies, Inc. (The) in a research report on Monday, June 5th. Zacks Investment Research upgraded Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $226.00 target price for the company in a research report on Wednesday, May 3rd. Jefferies Group LLC restated a “buy” rating and set a $250.00 target price (up previously from $220.00) on shares of Cooper Companies, Inc. (The) in a research report on Saturday, June 3rd. Stifel Nicolaus raised their target price on Cooper Companies, Inc. (The) from $220.00 to $231.00 and gave the stock a “buy” rating in a research report on Friday, June 2nd. Finally, Guggenheim started coverage on Cooper Companies, Inc. (The) in a research report on Thursday, June 29th. They set a “neutral” rating for the company. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $242.00.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Insider Buying and Selling by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

What are top analysts saying about Cooper Companies Inc. (The)? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cooper Companies Inc. (The) and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit